| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ANIK | Common Stock | Options Exercise | $0 | +14,420 | +13% | $0.000000 | 129,614 | 11 Mar 2024 | Direct | F1, F2 |
| transaction | ANIK | Common Stock | Tax liability | $177,254 | -6,973 | -5.4% | $25.42 | 122,641 | 11 Mar 2024 | Direct | F3, F4 |
| transaction | ANIK | Common Stock | Options Exercise | $0 | +20,001 | +16% | $0.000000 | 142,642 | 11 Mar 2024 | Direct | F5 |
| transaction | ANIK | Common Stock | Tax liability | $164,544 | -6,473 | -4.5% | $25.42 | 136,169 | 11 Mar 2024 | Direct | F4, F6 |
| transaction | ANIK | Common Stock | Options Exercise | $0 | +30,059 | +22% | $0.000000 | 166,228 | 11 Mar 2024 | Direct | F7 |
| transaction | ANIK | Common Stock | Tax liability | $374,832 | -14,534 | -8.7% | $25.79 | 151,694 | 11 Mar 2024 | Direct | F8, F9 |
| holding | ANIK | Common Stock | 11,742 | 11 Mar 2024 | Revocable Trust | F10 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ANIK | Restricted Stock Unit | Options Exercise | $0 | -14,420 | -100% | $0.000000* | 0 | 11 Mar 2024 | Common Stock | 14,420 | $0.000000 | Direct | F11 |
| transaction | ANIK | Restricted Stock Unit | Options Exercise | $0 | -20,001 | -33% | $0.000000 | 40,003 | 11 Mar 2024 | Common Stock | 20,001 | $0.000000 | Direct | F12 |
| transaction | ANIK | Restricted Stock Unit | Options Exercise | $0 | -30,059 | -50% | $0.000000 | 30,060 | 11 Mar 2024 | Common Stock | 30,059 | $0.000000 | Direct | F13 |
| Id | Content |
|---|---|
| F1 | Reflects the third and final vesting installment of Restricted Stock Units (RSUs) granted on March 9, 2021. |
| F2 | Includes the following shares acquired under the Anika Therapeutics, Inc. Employee Stock Purchase Plan: 152 shares purchased on May 12, 2023 and 787 shares purchased on November 14, 2023. |
| F3 | Reflects an aggregate of 6,973 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2024. |
| F4 | Reflects the closing price of ANIK common stock on March 8, 2024, the trading day prior to which the vesting of RSUs gave rise to tax withholding obligations. |
| F5 | Reflects the first vesting installment of RSUs granted on March 9, 2023. |
| F6 | Reflects an aggregate of 6,473 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2024. |
| F7 | Reflects the second vesting installment of RSUs granted on March 11, 2022. |
| F8 | Reflects an aggregate of 14,534 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 11, 2024. |
| F9 | Reflects the closing price of ANIK common stock on March 11, 2024, the trading day on which the vesting of RSUs gave rise to tax withholding obligations. |
| F10 | Consists of shares transferred by Dr. Blanchard to The Cheryl R. Blanchard Amended and Restated Revocable Trust dated December 19, 2014, of which Dr. Blanchard is a beneficiary and the sole trustee. |
| F11 | Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2022. |
| F12 | Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2024. |
| F13 | Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 11, 2023. |